OHB's Order Book Is Full, but the Profit-and-Cash Test Is Only Beginning

OHB shares came under heavy selling pressure after the German space and technology group reported nine-month figures that left the market with an uncomfortable question: how convincingly is the company converting its growth into earnings and cash? The stock fell 7.5% on Thursday, according to dpa-AFX, with the disappointing adjusted operating result and a weaker-than-expected adjusted free cash flow cited as the triggers.

The scale of the miss was laid out by JPMorgan analyst David Perry, who noted that third-quarter adjusted operating profit came in 7% below the analyst consensus. Perry kept his "Overweight" rating and a price target of EUR 300. Jefferies analyst Chloe Lemarie, meanwhile, stuck with "Buy" and a EUR 280 target, describing the quarter as solid at first glance and arguing that profitability offset a softer revenue performance.

Growth on paper, pressure at the bottom line

The nine-month numbers themselves tell a story of expansion. Total output for the first nine months of 2026 reached EUR 946.5 million, with adjusted EBITDA of EUR 99.7 million and adjusted EBIT of EUR 66.9 million. Yet net income for the period fell to EUR 19.137 million from EUR 24.384 million a year earlier — a drop of about 22%.

That gap between operating progress and a shrinking bottom line sits at the heart of the debate. Investors now have to weigh two yardsticks at once: the business can improve on the prior year and still fall short of expectations. For the share price, how reliably OHB clears the bar it sets for itself matters as much as the direction of growth.

A backlog that needs to prove itself

The commercial foundation is substantial. OHB reported order intake of EUR 2.3 billion for 2026, an order backlog of EUR 3,937 million after nine months, and a pipeline of around EUR 20 billion. Those figures mark different stages of the business, and the investor question is how much of that volume translates into profitable output and improved cash generation.

NuWays confirmed its buy recommendation on the stock with an unchanged price target of EUR 340, even as it trimmed its estimates for 2026 and 2027, citing somewhat weaker growth and higher one-off costs. The company itself reaffirmed its 2026 guidance, still expecting total output of around EUR 1.4 billion and an adjusted EBITDA margin of 10.5–11.0%.

The next test comes on the calendar: the Deutsches Eigenkapitalforum runs from 23 to 25 November 2026. After the sell-off, attention will focus on how the company turns its order book into economic results — and whether operating progress can finally be matched by delivered earnings and cash flow.